These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20496551)

  • 1. Chemotherapy in biliary tract cancer.
    Tonini G; Frato ME; Vincenzi B; Santini D
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):371-4. PubMed ID: 20496551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted therapy in biliary tract cancer: 2009 update.
    Tonini G; Virzì V; Fratto ME; Vincenzi B; Santini D
    Future Oncol; 2009 Dec; 5(10):1675-84. PubMed ID: 20001803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging treatment with systemic chemotherapy and targeted agents for biliary cancers.
    Boku N
    Curr Opin Investig Drugs; 2010 Jun; 11(6):653-60. PubMed ID: 20496260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary tract cancers: molecular profiling as a tool for treatment decisions. A literature review.
    Berardi R; Scartozzi M; Freddari F; Squadroni M; Santinelli A; Bearzi I; Fabris G; Cascinu S
    Cancer Treat Rev; 2006 Aug; 32(5):333-47. PubMed ID: 16762510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgical outcome of biliary tract cancer with postoperative chemotherapy].
    Sugawara G; Ebata T; Yokoyama Y; Igami T; Kokuryo T; Tsunoda N; Fukaya M; Uehara K; Itatsu K; Yoshioka Y; Nagino M
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1483-5. PubMed ID: 23130375
    [No Abstract]   [Full Text] [Related]  

  • 6. Guidelines for chemotherapy of biliary tract and ampullary carcinomas.
    Furuse J; Takada T; Miyazaki M; Miyakawa S; Tsukada K; Nagino M; Kondo S; Saito H; Tsuyuguchi T; Hirata K; Kimura F; Yoshitomi H; Nozawa S; Yoshida M; Wada K; Amano H; Miura F; ; ;
    J Hepatobiliary Pancreat Surg; 2008; 15(1):55-62. PubMed ID: 18274844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapy.
    Thomas MB
    Crit Rev Oncol Hematol; 2007 Jan; 61(1):44-51. PubMed ID: 17164111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Present situation of and prospects for standardization of surgery for biliary tract cancer].
    Endo I; Shimada H
    Nihon Geka Gakkai Zasshi; 2003 May; 104(5):404-11. PubMed ID: 12774525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surgical outcome of biliary tract cancer with neoadjuvant chemotherapy].
    Kato A; Shimizu H; Yoshidome H; Otsuka M; Furukawa K; Yoshitomi H; Takeuchi D; Takayashiki T; Kuboki S; Suzuki D; Nakajima M; Miyazaki M
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1486-9. PubMed ID: 23133873
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current aspects of chemotherapy of metastatic pancreatic and biliary tract carcinomas].
    Bokemeyer C; Kollmannsberger C; Oettle H; Kanz L
    Praxis (Bern 1994); 2000 Sep; 89(39):1545-52. PubMed ID: 11068508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward personalized treatment of advanced biliary tract cancers.
    Geynisman DM; Catenacci DV
    Discov Med; 2012 Jul; 14(74):41-57. PubMed ID: 22846202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of biliary tract carcinomas].
    Delbaldo C; Laurent A; Grenier J; Cherqui D; Luciani A; Piedbois P
    Rev Prat; 2009 Apr; 59(4):469-73. PubMed ID: 19462864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional chemotherapy in biliary tract cancers--a single institution experience.
    Melichar B; Cerman J; Dvorák J; Jandík P; Mergancová J; Melicharová K; Tousková M; Krajina A; Voboril Z
    Hepatogastroenterology; 2002; 49(46):900-6. PubMed ID: 12143237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer chemotherapy in the era of targeted therapy.
    Michael A; Syrigos K; Pandha H
    Prostate Cancer Prostatic Dis; 2009; 12(1):13-6. PubMed ID: 18521103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prospective randomized trial comparing modified FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus 5-FU alone for the treatment of non-resectable pancreatic and biliary tract carcinomas (the 1st trial in non-resectable patients). Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
    Takada T; Kato H; Sasaki M; Matsushiro T; Yamauchi H; Kajihara T; Watanabe G; Hanaue H; Yoshida K; Shimizu T
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1295-301. PubMed ID: 1503483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in photodynamic therapy for the treatment of hilar biliary tract cancer.
    Kiesslich T; Neureiter D; Wolkersdörfer GW; Plaetzer K; Berr F
    Future Oncol; 2010 Dec; 6(12):1925-36. PubMed ID: 21142865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy for colon cancer: present and perspectives.
    De Dosso S; Sessa C; Saletti P
    Cancer Treat Rev; 2009 Apr; 35(2):160-6. PubMed ID: 19013023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downstaging chemotherapy and alteration in the classic computed tomography/magnetic resonance imaging signs of vascular involvement in patients with pancreaticobiliary malignant tumors: influence on patient selection for surgery.
    Donahue TR; Isacoff WH; Hines OJ; Tomlinson JS; Farrell JJ; Bhat YM; Garon E; Clerkin B; Reber HA
    Arch Surg; 2011 Jul; 146(7):836-43. PubMed ID: 21768431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.